NCT04185779 is a clinical trial of Colonoscopy in Colorectal Cancer, sponsored by South Tyneside and Sunderland NHS Foundation Trust.

Who is sponsoring NCT04185779?

NCT04185779 is sponsored by South Tyneside and Sunderland NHS Foundation Trust.

What drugs are being tested in NCT04185779?

Interventions in NCT04185779: Colonoscopy.

What condition does NCT04185779 study?

NCT04185779 studies Colorectal Cancer, Colorectal Adenoma, Colorectal Neoplasm, Predictive Cancer Model, Model.

Is NCT04185779 still recruiting?

NCT04185779 is currently recruiting now. Last updated 22 October 2020.

Last reviewed 2020-10-22 · How we verify

NCT04185779

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

COLO-COHORT (Colorectal Cancer Cohort) Study

Recruiting now Last updated 22 October 2020

What this trial tests

trial testing Colonoscopy in Colorectal Cancer in 15,000 participants. Currently enrolling.

Timeline

13 December 2019

Primary endpoint
15 August 2024

15 August 2026

Quick facts

Lead sponsor	South Tyneside and Sunderland NHS Foundation Trust
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	15,000
Start date	13 December 2019
Primary completion	15 August 2024
Estimated completion	15 August 2026
Sites	3 locations across United Kingdom

Drugs / interventions tested

Colonoscopy

Conditions studied

Colorectal Cancer — all drugs for Colorectal Cancer →
Colorectal Adenoma — all drugs for Colorectal Adenoma →
Colorectal Neoplasm — all drugs for Colorectal Neoplasm →
Predictive Cancer Model — all drugs for Predictive Cancer Model →

Sponsor

South Tyneside and Sunderland NHS Foundation Trust

Who can join

18 and older, any sex, with Colorectal Cancer or Colorectal Adenoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a cross-sectional study aimed at identifying factors which best predicts patients at high risk of colorectal cancer or colorectal adenomas and to develop a risk prediction model.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

What Is Known about Theragnostic Strategies in Colorectal Cancer.
Parisi A, Porzio G, Pulcini F, Cannita K, et al · · 2021 · cited 13× · PMID 33535557 · DOI 10.3390/biomedicines9020140
The COLO-COHORT (Colorectal Cancer Cohort) study: Protocol for a multi-centre, observational research study and development of a consent-for-contact research platform.
Hampton JS, Koo S, Dobson C, Stewart CJ, et al · · 2022 · cited 6× · PMID 35470953 · DOI 10.1111/codi.16160
Taxonomic and functional profiling of fecal metagenomes for the early detection of colorectal cancer.
Wu X, Tang Z, Zhao R, Wang Y, et al · · 2023 · cited 2× · PMID 37601681 · DOI 10.3389/fonc.2023.1218056

Verify or expand the search:

Other trials of Colonoscopy

Trials testing the same drug.

NCT07361575 — Study Comparing the Quality of Colon Cleanliness With Prepackaged LRD (Low-residue Diet) vs. Guided (POG). · NA · not yet recruiting
NCT06983639 — Randomized Trial Comparing Fecal Testing (FIT) to Colonoscopy for Post-polypectomy Surveillance · NA · recruiting
NCT05630794 — Testing for Safety and Colorectal Cancer Preventive Effects of ONC201 · Phase 1 · recruiting
NCT07140679 — Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or · Phase 2 · recruiting
NCT07503847 — Shared Decision-Making for Colorectal Cancer Screening in High-Risk First-Degree Relatives Aged 40-49 · NA · enrolling by invitation

Other recruiting trials for Colorectal Cancer

Currently open trials in the same condition.

NCT07152821 — Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcino · Phase 3 · recruiting
NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
NCT07523919 — Functional and Respiratory Determinants of Long-Term Colorectal Cancer Outcomes · recruiting
NCT07529301 — Functional and Respiratory Predictors of Early Postoperative Outcomes · recruiting

Other South Tyneside and Sunderland NHS Foundation Trust trials

Trials by the same sponsor.

NCT06822023 — Virtual Reality and Its Use in Reducing Perioperative Stress in Cataract Surgery · NA · not yet recruiting
NCT06636292 — VRDD in Upper Gastrointestinal Endoscopy · NA · completed
NCT06104137 — MOOC Applications Related to Shared Decision Making in Bariatric Surgery · NA · unknown
NCT04723758 — COLO-DETECT: Can an Artificial Intelligence Device Increase Detection of Polyps During Colonoscopy? · NA · completed
NCT04637685 — The Effect of Infusion Pressure on the Outcomes of Phacoemulsification Surgery; the ENHANSE Study · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04185779 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by South Tyneside and Sunderland NHS Foundation Trust
Last refreshed: 22 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04185779.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing